We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Colorectal cancer is more likely to develop due to the interaction of various factors, such as diet, lifestyle and genetic inheritance.
Diet. Diet contributes to the development of colorectal cancer; in fact eating red meats, processed meats and very well-done meats or which have been in direct contact with flames has been associated with a greater risk of suffering colorectal cancer. On the other hand, a diet high in fibre, vegetables, fruit and milk or other dairy products seems to have a protective effect. Nevertheless, despite these associations, researchers have not yet clearly identified which foods or nutrients are the main causes of colorectal cancer.
Lifestyle. A lack of exercise, overweight and obesity, alcohol consumption and tobacco consumption all favour the appearance of colorectal cancer.
Hereditary factors. Genetic inheritance plays an important role in the development of colorectal cancer. As such, hereditary colorectal cancer corresponds to 5–10% of all occurrences and up to 20–25% of cases feature relatives who have also had colorectal cancer in which genetic inheritance is believed to be involved.
However, in most cases (70–75%) colorectal cancer is sporadic, in other words, it is not caused by mutations in the genes inherited from our parents but is instead related to diet and lifestyle.
Antonio Maria Lacy FortunyGeneral and Digestive SurgeryGastrointestinal Surgery Department
Estela Pineda LosadaOncologyMedical Oncology Department
Francesc Balaguer PrunesGastroenterologistGastroenterology Department
Mª Rosa Costa QuintàsNurseGastrointestinal Surgery Department
Published: 20 February 2018
Updated: 20 February 2018
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.